Purchase Order 75N92025K00001

Award Date 7/9/25
Potential Completion Date 8/9/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,120 firm fixed-price purchase order awarded by the National Cancer Institute, part of the National Institutes of Health, to UK Biobank Limited, a non-profit organization. The contract provides UK Biobank Limited's large-scale biomedical database containing de-identified genetic, lifestyle, and health information from over 500,000 UK participants as a research resource for approved scientific researchers to analyze. The award, with a completion date of February 6, 2026,...
This federal contract award, valued at $11,550.24, was issued by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization based in the United Kingdom. The contract is for a 36-month extension to provide Tier 3 level access to UK Biobank's large-scale biomedical database, which contains de-identified genetic, lifestyle, and health information from over 500,000 participants in the UK. This...
This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency within the U.S. Department of Health and Human Services, to UK Biobank LIMITED, a non-profit organization in the United Kingdom. The $14,129 contract is for Tier 3 data access services, providing researchers at various National Institutes of Health (NIH) agencies with access to UK Biobank's comprehensive medical and genomic datasets to support advanced biomedical research. The...
This firm fixed-price purchase order contract, valued at $12,369.70, was awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization. The contract provides Tier 3 access to UK Biobank's large-scale, de-identified biomedical database containing genetic, lifestyle, and health information from over 500,000 participants in the United Kingdom. This data access supports biomedical research projects across...
This purchase order awards UK Biobank Limited $12,934.99 to provide Tier 3 access fees under a potential value of the same amount. As a non-profit organization, the contractor will deliver its standard biobank datasets and related laboratory and testing services to the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute in Bethesda, Maryland by November 14, 2024. The firm fixed price contract vehicle was awarded on November 15, 2023...
This firm fixed-price purchase order contract was awarded by the National Eye Institute (NEI), a component of the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization. The $11,630.34 contract provides access to UK Biobank's large-scale biomedical database containing genetic, lifestyle, and health information from over 500,000 UK participants. This biobank serves as a research resource for approved scientific studies, and the contract facilitates projects...
UK Biobank Limited has been awarded a $13,500 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to provide laboratory and testing services. The firm fixed price contract runs from December 2023 through March 2026 and will be performed by UK Biobank in Great Britain. No additional details were provided on the original solicitation or work scope. The award does not appear to be associated with a...
The National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism awarded UK Biobank Limited a three-year, firm fixed price purchase order valued at approximately thirteen thousand three hundred eighty-eight U.S. dollars to provide access to the United Kingdom Biobank dataset. As the prime contractor, UK Biobank Limited will deliver its biomedical database of genetic and health information to support research efforts of the National Institute on Alcohol Abuse and Alcoholism....
This is a $100,000.00 firm-fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to King's College London, a prestigious research institution in the United Kingdom. The contract is for COVID-19 genomic testing and demographic data from the TwinsUK project, which will be used to investigate the genetic regulation of the immune system and to stratify COVID-19 severity and symptom types. The contract does not...
The National Institutes of Health National Cancer Institute awarded a $160,000 firm fixed price Blanket Purchase Agreement Call contract to the Department of Health and Healthcare Products Regulatory Agency for a 12-month license providing access to National Library of Medicine United Kingdom Clinical Practice Research Datalink datasets. The contract has no set-aside designation. Under this contract, the Department of Health and Healthcare Products Regulatory Agency will deliver requested access...

This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. government, to UK Biobank LIMITED, a non-profit organization in the United Kingdom. The $10,433.80 contract provides a 36-month extension for Tier 2 data access fees, allowing researchers at various National Institutes of Health agencies to access UK Biobank's extensive database of anonymized genetic, lifestyle, and health information from over 500,000 UK participants. This contract, which does not have a set-aside designation, is part of UK Biobank LIMITED's ongoing role as a critical intermediary supporting advanced biomedical research in the United States by providing comprehensive medical datasets to federal research institutions.

Generated 7/17/25, 6:16 PM